Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)
Selected Variant
BEB-Y10-1mg
Size: 1 mg
A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) . Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Product Specifications
Background
CAS Number
9007-83-4
Host
Hybridoma
Origin Species
Mouse
Target
Bevacizumab
Conjugation
Unconjugated
Stability
Purity
0.95
Bioactivity
Immobilized Bevacizumab at 1 μg/mL (100 μL/well) can bind Anti-Bevacizumab Antibody (AY10) (Cat. No. BEB-Y10) with a linear range of 0.39-25 ng/mL.
Format
Powder
Buffer
Tris with Glycine, Arginine and NaCl, pH7.5
Additives
Trehalose
Additionnal Information
Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments
Shipping Conditions
RT
Storage Conditions
-20°C
Package Size
500ug*2
Host or Source
Hybridoma
Species
Mouse
Preservative
Trehalose
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mitochondrial Marker (MTC02), CF568 conjugate, 0.1mg/mL
Ep-CAM / CD326 (EGP40/837), CF488A conjugate, 0.1mg/mL
Cytokeratin 19 (A53-B/A2.26 + BA17), CF647 conjugate, 0.1mg/mL
